LncRNA TP73‐AS1 regulates miR ‐495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A

Management of recurrent nasopharyngeal carcinoma: current perspectives

(2019) F Perri et al.   OncoTargets and Therapy

Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China

(2019) Ting Zhou et al.   Cancer Medicine

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma

(2019) Sumei Wang et al.   Frontiers in Oncology

Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines

(2019) Mei Mei Guan et al.   MEDICAL SCIENCE MONITOR

LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway

(2018) Zhiyong Tuo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR-495

(2018) Yan-Xing Guan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China

(2018) Yong-Qiao He et al.   EBioMedicine

LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway

(2018) Chunfeng Liu et al.   BIOSCIENCE REPORTS

TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition

(2017) Jia Yao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation

(2017) Shaling Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma

(2017) A G Solimando et al.   LEUKEMIA

Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer

(2017) Yanyan Tang et al.   Molecular Cancer

Expression, regulation and function of miR-495 in healthy and tumor tissues

(2017) Hongli Chen et al.   Oncology Letters

LncRNAs regulate cancer metastasis via binding to functional proteins

(2017) Liting Yang et al.   Oncotarget

Nasopharyngeal carcinoma

(2016) Melvin L K Chua et al.   LANCET

MicroRNA (miRNA) in cancer

(2015) Kaladhar B Reddy   Cancer Cell International

MicroRNA-495 induces breast cancer cell migration by targeting JAM-A

(2014) Minghui Cao et al.   Protein & Cell

Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression

(2013) Min Zhang et al.   PLoS One

MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3

(2013) Heying Chu et al.   TUMOR BIOLOGY

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6

(2013) Shu-Mei Chen et al.   World Journal of Surgical Oncology

miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3

(2012) Zhengrong Li et al.   CANCER LETTERS

MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma

(2012) Heping Yang et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia

(2012) X. Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The prevalence and prevention of nasopharyngeal carcinoma in China

(2011) Su-Mei Cao et al.   Chinese Journal of Cancer

JAM-A expression positively correlates with poor prognosis in breast cancer patients

(2009) Elaine A. McSherry et al.   INTERNATIONAL JOURNAL OF CANCER